Home Featured Page 105

Featured

Latest

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

Algernon Pharmaceuticals Announces 4 for 1 Forward Share Split

Blossom – Making Psychedelic Education Accessible with David Drapkin from Psychedelics...

Fierce Healthcare – Psychedelics Today to offer yearlong certificate course on...

Taos News – Psychedelic therapy gains support in NM, momentum nationwide

AP News – Psychedelics Today Re-Launches Vital Diversity, Equity and Inclusion...

AP News – Psychedelics Today Launches “Psychedelics Tonight”

The Pharma Letter – The psychedelic medicine renaissance: how could the...

Enosis Therapeutics announces its response to Australian TGA decision, Plans to...

COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results ...

1...104105106...301 Page 105 of 301

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

Algernon Pharmaceuticals Announces 4 for 1 Forward Share Split

Blossom – Making Psychedelic Education Accessible with David Drapkin from Psychedelics...

PT394 – We Are The Medicine

Fierce Healthcare – Psychedelics Today to offer yearlong certificate course on...

Taos News – Psychedelic therapy gains support in NM, momentum nationwide

AP News – Psychedelics Today Re-Launches Vital Diversity, Equity and Inclusion...

AP News – Psychedelics Today Launches “Psychedelics Tonight”

The Pharma Letter – The psychedelic medicine renaissance: how could the...

Enosis Therapeutics announces its response to Australian TGA decision, Plans to...

COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results ...

EDITOR PICKS

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY